Search results

Am only able to skim it, but don't understand how the researchers conclude that the pandemic is a resolved matter. Readers might misunderstand and believe that Covid generating Long Covid is a thing of the past. From the introduction: - However, now that the pandemic is resolved, we need to...

Thanks for summarising the media coverage on this study, @Utsikt Just want to add that one of the authors, Brurberg, also is among the authors of the Larun Cochrane review on GET as ME treatment.

Article today in Newsweek about the study with comments from among others Al-Aly and Iwasaki: 'Disabling' Chronic Illness in Children Not Taken Seriously: Experts quote: It was found that 101, or 15 percent, of the 677 children who had previously tested positive for SARS-CoV-2 infection were...

Merged Key Points - from the abstract page Question Which prolonged symptoms in early childhood are associated with SARS-CoV-2 infection? Findings In the Researching COVID to Enhance Recovery (RECOVER)–Pediatrics cohort study including 472 infants/toddlers and 539 preschool-aged children...

CIDRAP - Persistent symptoms common in Uganda's Ebola Sudan survivors Quote: Frequency of clinician symptoms was 57.4% higher in Ebola survivors, especially musculoskeletal, neurologic, and ophthalmologic. The risk ratio for occurrence was highest for ophthalmologic and central nervous system...

Abstract Background The long-term health effects of ebolavirus disease (EVD) caused by the Sudan ebolavirus (SUDV) strain remain poorly characterized. Here, we assessed the nature, frequency, and persistence of post-EVD clinical symptoms among SUDV survivors 2 years after infection by comparing...

Kavita D. Nadendla, Christina Kokorelis, Danilo Buonseno, Luise Neundorff, Alba M. Azola, Peter C. Rowe & Laura A. Malone Abstract Purpose of Review Five years into the COVID-19 pandemic, long COVID in children and adolescents has emerged as a complex, chronic condition with distinct clinical...

Have cold allergy and during last episode struggled with breathing and felt generally very unwell, so guess it's out of the question to even try. But a specialist in infectious diseases mentioned it as something perhaps worth trying for my ME - 30 years ago. He didn't have any special knowledge...

Anthony L. Komaroff has written a commentary in the same journal edition based on the paper of the thread: Growing recognition of post-acute infection syndromes Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and long COVID affect large numbers of people, and constitute a...

In a recent press release from the Norwegian Labour and Welfare Administration ME, along with autism and PTSD, are mentioned as illnesses young people are increasingly diagnosed with, and the reason behind them receiving benefits. Chief doctor Marit Hermansen says she doesn't know why more...

Physiotherapist Michelle Bull - Living with ME/CFS and Long Covid - Managing symptoms

GP Anniken Aase Sommerfelt on: "ME/CFS: Perspectives from a General Practitioner"

Brian Hughes on paradigm shifts with the ME/CFS NICE guidelines as case study.

Kristian Sommerfelt and Trude Schei on the development of FUNCAP, a questionnaire to asses functional capacity in patients with PEM

Rob Wüst on PEM and muscle abnormalities

David Systrom on circulatory and respiratory aspects.

New talk released. Professor David Putrino on "New insights from the Covid pandemic".

The talk that professor Karl Johan Tronstad gave titled "Metabolomics and cellular energy supply" is now available He speaks in Norwegian but there are English subtitles.

Great to see Tuller again in a new episode from the podcast This Week in Virology with professor Vincent Racaniello. "David Tuller returns to TWiV to discuss RFK Jr. and the trashing of American public health, rituximab and ME/CFS, The Sick Times, the Cochrane Mess, a Norwegian Long Covid...

This was done with Rituximab for ME/CFS as well. As far as I understand this is common practice? Should it ever result into some profit it will go to the public health institution Helse Bergen which is the "owner" of the patent, and not into the researcher's own pockets.